Abattis Bioceuticals Corp.
ATTBF · OTC
9/30/2019 | 9/30/2018 | 9/30/2017 | 9/30/2016 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $2 | $4 | $1 | $0 |
| Short-Term Investments | $0 | $5 | $0 | $0 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $1 | $1 | $0 | $0 |
| Total Curr. Assets | $4 | $10 | $1 | $0 |
| Property Plant & Equip (Net) | $1 | $1 | $1 | $0 |
| Goodwill | $3 | $0 | $0 | $0 |
| Intangibles | $12 | $0 | $0 | $1 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $16 | $1 | $1 | $1 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $19 | $11 | $1 | $1 |
| Liabilities | – | – | – | – |
| Payables | $0 | $0 | $0 | $1 |
| Short-Term Debt | $1 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $3 | $0 | $0 | $0 |
| Total Curr. Liab. | $5 | $0 | $0 | $1 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $4 | $0 | $0 | $0 |
| Total NC Liab. | $4 | $0 | $0 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $9 | $0 | $0 | $1 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $114 | $109 | $22 | $15 |
| Retained Earnings | -$102 | -$100 | -$23 | -$15 |
| AOCI | -$0 | $2 | -$0 | $1 |
| Other Equity | -$1 | $0 | $2 | $0 |
| Total Equity | $11 | $11 | $2 | $1 |
| Supplemental Information | – | – | – | – |
| Minority Interest | -$0 | -$0 | -$1 | -$0 |
| Total Liab. & Tot. Equity | $19 | $11 | $1 | $1 |
| Net Debt | -$0 | -$4 | -$1 | -$0 |